InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by London, John. Director active across 1 company, notably Crescita Therapeutics Inc.. Cumulatively, 6 reports have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €172k. History available since 3 June 2026. The latest transaction was disclosed on 3 June 2026 (22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition). Regulator: SEDI. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
John London is a declarant linked to Crescita Therapeutics Inc. as 4 - Director of Issuer. He has 6 filings in total, and the 6 sampled filings are dated 2026-06-08, with EUR 172314 of buys and EUR 0 of sells, the modal transaction nature being 22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition.